Early results with the use of heparin-bonded stent graft to rescue failed angioplasty of chronic femoropopliteal occlusive lesions: TASC D lesions have a poor outcome

CardioVascular and Interventional Radiology

Volumn 35, Issue 5, 2012, Pages 1023-1028

  Kuhan, Ganesh ^a   Abisi, Said ^a   Braithwaite, Bruce D ^a   MacSweeney, Shane T R ^a   Whitaker, Simon C ^a   Habib, Said B ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Occlusion; Patency; Peripheral arterial disease; Stent graft

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC FEMOROPOPLITEAL OCCLUSION; BYPASS SURGERY; CLAUDICATION; CLINICAL ARTICLE; CRITICAL LIMB ISCHEMIA; DISEASE CLASSIFICATION; FEMALE; HEPARIN BONDED STENT GRAFT; HUMAN; IN-STENT RESTENOSIS; LEG AMPUTATION; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STENT; TRANSATLANTIC INTERSOCIETY CONSENSUS CLASSIFICATION; TREATMENT FAILURE; VASCULAR PATENCY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ANTICOAGULANTS; ARTERIAL OCCLUSIVE DISEASES; CHRONIC DISEASE; COMORBIDITY; DRUG-ELUTING STENTS; FEMALE; FEMORAL ARTERY; HEPARIN; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POPLITEAL ARTERY; PROPORTIONAL HAZARDS MODELS; RETREATMENT; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84867574909     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0400-6     Document Type: Article

References (23)

1. Hiatt WR, Hoag S, Hamman RF (1995) Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 91:1472-1479
2. Schlager O, Dick P, Sabeti S et al (2005) Long-segment SFA stentingthe dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 12:676-684
3. Greenhalgh J, Hockenhull J, Rao N et al (2010) Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Database Syst Rev (5):CD004587
4. Duda SH, Bosiers M, Lammer J et al (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16:331-338
5. Dake MD, Ansel GM, Jaff MR et al (2011) Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 4:495-504
6. Wong G, Li JM, Hendricks G et al (2008) Inhibition of experimental neointimal hyperplasia by recombinant human thrombomodulin coated ePTFE stent grafts. J Vasc Surg 47:608-615
7. Clowes AW, Karnowsky MJ (1977) Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265(5595):625-626
8. Norgren L, Hiatt WR, Dormandy JA et al (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33(suppl 1):S1-S75
9. Rutherford RB, Baker JD, Ernst C et al (1997) Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26:517-538
10. Kougias P, Chen A, Cagiannos C et al (2009) Subintimal placement of covered stent versus subintimal balloon angioplasty in the treatment of long-segment superficial femoral artery occlusion. Am J Surg 198:645-649
11. Lammer J, Dake MD, Bleyn J et al (2000) Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology 217:95-104
12. Kedora J, Hohmann S, Garrett W et al (2007) Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 45:10-16
13. Saxon RR, Dake MD, Volgelzang RL et al (2008) Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 19:823-832
14. Lammer J (2001) Femoropopliteal artery obstructions: from the balloon to the stent-graft. Cardiovasc Intervent Radiol 24:73-83
15. Davies MG, Saad WE, Peden EK et al (2008) Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg 48:619-625
16. DeRubertis BG, Pierce M, Chaer RA et al (2007) Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention. J Vasc Surg 46:709-716
17. Clark TW, Groffsky JL, Soulen MC (2001) Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 12:923-933
18. Capek P, McLean GK, Berkowitz HD (1991) Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 83(2 suppl):I70-I80
19. Gray BH, Olin JW (1997) Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease. Semin Vasc Surg 10:8-16
20. Johnston KW (1992) Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 183:767-771
21. Alimi YS, Hakam Z, Hartung O et al (2008) Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency? Eur J Vasc Endovasc Surg 35:346-352
22. Hartung O, Otero A, Dubuc M et al (2005) Efficacy of Hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia: a comparative study with claudicants. Eur J Vasc Endovasc Surg 30:300-306
23. Adam DJ, Beard JD, Cleveland T et al (2005) Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366(9501):1925-1934